STOCK TITAN
  1. Home
  2. News
  3. MASI

Masimo Corp - MASI STOCK NEWS

Welcome to our dedicated news page for Masimo (Ticker: MASI), a resource for investors and traders seeking the latest updates and insights on Masimo.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Masimo's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Masimo's position in the market.

News
Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches
Rhea-AI Summary
Masimo (NASDAQ: MASI) celebrates the Federal Circuit's decision to lift the temporary stay on the import ban of certain Apple Watch models, reinstating the U.S. International Trade Commission's import ban and cease and desist order on Apple watches infringing Masimo's patented pulse oximetry technology. The CEO, Joe Kiani, emphasizes the importance of upholding American inventors' rights and highlights the superiority of Masimo's pulse oximetry technology over Apple Watch's. Masimo's FDA-cleared W1® health watch is positioned as a more reliable alternative, with proven benefits in medical settings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
none
-
News
Masimo Announces New Member of the Board of Directors
Rhea-AI Summary
Masimo (NASDAQ: MASI) has appointed Bob Chapek, former CEO of The Walt Disney Company, to its Board of Directors. Chapek's successful leadership at Disney during the global COVID-19 pandemic, strategic realignment of media and entertainment divisions, and expansion of streaming services make him a valuable addition to Masimo's growth plans. Masimo's Chairman and CEO, Joe Kiani, expressed excitement about Chapek's role in advancing the company's hospital to home strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
management
-
News
Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance
Rhea-AI Summary
Masimo Corporation (MASI) announced preliminary financial results for Q4 and full-year 2023, with consolidated revenue of $541-551 million for Q4 and $2,041-2,051 million for full-year 2023. Full-year 2024 guidance includes consolidated revenue of $2,045-2,165 million, with updated non-GAAP earnings per diluted share of $3.44-3.60.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.55%
Tags
earnings
News
Masimo Receives FDA Clearance for Stork™ Baby Monitoring System
Rhea-AI Summary
Masimo (NASDAQ: MASI) receives FDA clearance for Stork™, a baby monitoring system for prescription use with babies 0-18 months. Stork provides continuous monitoring of oxygen saturation, pulse rate, and skin temperature, with alarms, for sick and healthy babies at home. It leverages the same Masimo sensor technology used in hospitals and is now available for prescription use as a medical device for healthy or sick babies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.16%
Tags
clinical trial
-
News
New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation
Rhea-AI Summary
Masimo (NASDAQ: MASI) announces findings from a study on the association of Masimo ORi™ and arterial partial pressure of oxygen in patients undergoing non-cardiac thoracic surgery during one-lung ventilation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.73%
Tags
none
-
News
Masimo to Present in Piper Sandler 35th Annual Healthcare Conference
Rhea-AI Summary
Masimo (MASI) to participate in Piper Sandler 35th Annual Healthcare Conference on November 29, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences
News
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
Rhea-AI Summary
Masimo (NASDAQ: MASI) Receives FDA Clearance for W1 Medical Watch for OTC and Rx Use
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
clinical trial
-
News
Masimo to Present in Jefferies London Healthcare Conference
Rhea-AI Summary
Masimo (NASDAQ: MASI) to present at Jefferies London Healthcare Conference on November 15, 2023, with live webcast and replay available on company website
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
conferences
-
News
GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform
Rhea-AI Summary
GE HealthCare (GEHC) and Masimo (MASI) have announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse oximetry into GE HealthCare’s Portrait Mobile wireless and wearable patient monitoring solution. The integration will allow clinicians to leverage Masimo’s clinically proven oxygen saturation measurement technology to noninvasively detect and continuously monitor changes in patient status. This collaboration follows Portrait Mobile’s 510(k) clearance from the U.S. FDA in August 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
none
News
Masimo Announces New Member of the Board of Directors
Rhea-AI Summary
Masimo (NASDAQ: MASI) appoints Rolf A. Classon, an experienced medical technology executive, to its Board of Directors. Mr. Classon has held various management positions with major healthcare companies and brings extensive industry expertise to Masimo.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.71%
Tags
management
Stock MASI logo
Masimo Corp

Nasdaq:MASI

MASI Rankings

#957 Ranked by Market Cap
#4202 Ranked by Stock Gains
N/A Ranked by Dividends

MASI Stock Data

7.30B
44.60M
7.71%
96.37%
7.99%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
Irvine

About MASI

masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.